SARS-CoV-2 Omicron neutralization and risk of infection among elderly after a booster dose of Pfizer vaccine
View ORCID ProfileTimothée Bruel, Laurie Pinaud, Laura Tondeur, View ORCID ProfileDelphine Planas, Isabelle Staropoli, Françoise Porrot, Florence Guivel-Benhassine, Mikaël Attia, Stéphane Pelleau, Tom Woudenberg, Cécile Duru, Aymar Davy Koffi, Sandrine Castelain, Sandrine Fernandes-Pellerin, Nathalie Jolly, Louise Perrin De Facci, Emmanuel Roux, Marie-Noëlle Ungeheuer, Sylvie Van Der Werf, Michael White, View ORCID ProfileOlivier Schwartz, Arnaud Fontanet
doi: https://doi.org/10.1101/2022.03.30.22273175
Timothée Bruel
1Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France
2Vaccine Research Institute, Créteil, France
Laurie Pinaud
3Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France
Laura Tondeur
3Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France
Delphine Planas
1Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France
2Vaccine Research Institute, Créteil, France
Isabelle Staropoli
1Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France
Françoise Porrot
1Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France
Florence Guivel-Benhassine
1Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France
Mikaël Attia
4Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France
Stéphane Pelleau
5Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France
Tom Woudenberg
5Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France
Cécile Duru
6Hôpital de Crépy-en-Valois, Crépy-en-Valois, France
Aymar Davy Koffi
6Hôpital de Crépy-en-Valois, Crépy-en-Valois, France
Sandrine Castelain
7Laboratoire de virologie, CHU Amiens, AGIR UR4294, UPJV, Amiens, France
Sandrine Fernandes-Pellerin
8Center for Translational Science, Institut Pasteur, Paris, France
Nathalie Jolly
8Center for Translational Science, Institut Pasteur, Paris, France
Louise Perrin De Facci
9Clinical Investigation and access to bioresources (ICAReB) platform, Center for Translational Science, Institut Pasteur, Paris, France
Emmanuel Roux
9Clinical Investigation and access to bioresources (ICAReB) platform, Center for Translational Science, Institut Pasteur, Paris, France
Marie-Noëlle Ungeheuer
9Clinical Investigation and access to bioresources (ICAReB) platform, Center for Translational Science, Institut Pasteur, Paris, France
Sylvie Van Der Werf
4Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France
Michael White
5Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France
Olivier Schwartz
1Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France
2Vaccine Research Institute, Créteil, France
Arnaud Fontanet
3Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France
10Conservatoire National des Arts et Métiers, PACRI Unit, Paris, France
Article usage
Posted March 30, 2022.
SARS-CoV-2 Omicron neutralization and risk of infection among elderly after a booster dose of Pfizer vaccine
Timothée Bruel, Laurie Pinaud, Laura Tondeur, Delphine Planas, Isabelle Staropoli, Françoise Porrot, Florence Guivel-Benhassine, Mikaël Attia, Stéphane Pelleau, Tom Woudenberg, Cécile Duru, Aymar Davy Koffi, Sandrine Castelain, Sandrine Fernandes-Pellerin, Nathalie Jolly, Louise Perrin De Facci, Emmanuel Roux, Marie-Noëlle Ungeheuer, Sylvie Van Der Werf, Michael White, Olivier Schwartz, Arnaud Fontanet
medRxiv 2022.03.30.22273175; doi: https://doi.org/10.1101/2022.03.30.22273175
SARS-CoV-2 Omicron neutralization and risk of infection among elderly after a booster dose of Pfizer vaccine
Timothée Bruel, Laurie Pinaud, Laura Tondeur, Delphine Planas, Isabelle Staropoli, Françoise Porrot, Florence Guivel-Benhassine, Mikaël Attia, Stéphane Pelleau, Tom Woudenberg, Cécile Duru, Aymar Davy Koffi, Sandrine Castelain, Sandrine Fernandes-Pellerin, Nathalie Jolly, Louise Perrin De Facci, Emmanuel Roux, Marie-Noëlle Ungeheuer, Sylvie Van Der Werf, Michael White, Olivier Schwartz, Arnaud Fontanet
medRxiv 2022.03.30.22273175; doi: https://doi.org/10.1101/2022.03.30.22273175
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2695)
- Dermatology (230)
- Emergency Medicine (405)
- Epidemiology (12335)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4176)
- Geriatric Medicine (393)
- Health Economics (689)
- Health Informatics (2703)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3957)
- Nursing (215)
- Nutrition (587)
- Oncology (2085)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (308)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1134)
- Primary Care Research (463)
- Public and Global Health (6595)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (346)
- Surgery (457)
- Toxicology (56)
- Transplantation (192)
- Urology (170)